Although previous studies have suggested that LPAR6 served as an oncogene in hepatocellular carcinoma and pancreatic carcinoma, it is rational to consider, from our results, that in breast cancer, LPAR6 acts as an antitumor factor. Here, LPAR6 is linked to exocrine pancreatic carcinoma.